Live feed09:05:00·232dPRReleasevia QuantisnowSenti Bio to Present Updated Clinical Results of First-in-Class Logic Gated CD33/FLT3 Cell Therapy, SENTI-202, at the American Society of Hematology (ASH) Annual Meeting 2025ByQuantisnow·Wall Street's wire, on your screen.SNTI· Senti Biosciences Inc.Health Care
